| Multiple Sclerosis |
1 |
1 |
| Depression |
0 |
0.74 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.98 |
| Toxicology |
0 |
0.62 |
| Antidepressant drug |
0 |
0.99 |
| Hypertension |
0 |
0.47 |
| Drug Interaction |
0 |
0.33 |
| Multiple Sclerosis Relapse |
0 |
0.33 |
| Anxiety Disorder |
0 |
0.18 |
| Anxiety |
0 |
0.17 |
| Serotonin Syndrome |
0 |
0.17 |
| Neuroleptic Malignant Syndrome |
0 |
0.12 |
| Antipsychotics |
0 |
0.08 |
| Board Certification |
0 |
0.08 |
| Disease-Modifying Therapy |
0 |
0.08 |
| Hyperthermia |
0 |
0.08 |
| Interferon Beta |
0 |
0.08 |
| Multiple Sclerosis Risk |
0 |
0.08 |
| New York |
0 |
0.08 |
| Receptors |
0 |
0.08 |
| SNRI |
0 |
0.08 |
| Washington |
0 |
0.08 |
| Biologic Therapy |
0 |
0.07 |